Zobrazeno 1 - 10
of 340
pro vyhledávání: '"Jessica Leonard"'
Autor:
Elias Jabbour, Hagop Kantarjian, Ibrahim Aldoss, Pau Montesinos, Jessica Leonard, David Gomez, Maria Baer, Carlo Gambacorti-Passerini, James Mccloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Pankit Vachhani, Eunice Wang, Meliessa Hennessy, Niti Patel, Alexander Vorog, Bingxia Wang, Huilan Yao, Tammie Yeh, Josep Maria Ribera
Publikováno v:
HemaSphere, Vol 7, p e68516d0 (2023)
Externí odkaz:
https://doaj.org/article/f833a33b51b945e094c5af6cc6ac5e78
Autor:
Jessica Leonard, Joelle SJ Wolf, Michelle Degnin, Christopher A. Eide, Dorian LaTocha, Kyle Lenz, Beth Wilmot, Charles G. Mullighan, Mignon Loh, Stephen P Hunger, Brian J Druker, Marc M Loriaux, Jeffrey W Tyner, Bill H Chang
Publikováno v:
Haematologica, Vol 106, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/2901a1309bc34ddbb96064c714b750fc
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:878-882
Measurable residual disease (MRD) is an established component of acute lymphoblastic leukemia (ALL) management in both children and adults. Society guidelines and expert consensus documents include assessment of MRD as the standard of care following
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d9d0d5e456fdf551b517a8d6eb25f9
https://doi.org/10.1016/j.clml.2022.08.004
https://doi.org/10.1016/j.clml.2022.08.004
Autor:
Marcus T Altman, Alison H. Skalet, Phoebe Lin, Zane Staubach, Jessica Leonard, Jennifer Dunlap, Amr Zaki
Publikováno v:
RETINAL Cases & Brief Reports. 17:117-119
Purpose To describe a patient with a history of pre-B cell acute lymphoblastic leukemia (pre-B ALL) in remission, who developed recurrent alternating intraocular pre-B ALL manifesting with pseudohypopyon, uveal mass, and serous retinal detachment. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e952ec706d360ad611fadbcbc1a9aec
https://doi.org/10.1097/icb.0000000000001172
https://doi.org/10.1097/icb.0000000000001172
Autor:
Wendy Stock, Thomas B. Alexander, Charles G. Mullighan, Amanda Jacobson, Su Young Kim, Lindsey Rosenwinkel, Deeksha Vishwamitra, Jeremy A. Ross, Yan Sun, John C. Pesko, Bo Tong, Michelle Schmidt, Mohamed Badawi, Chunxu Qu, Yaqi Zhao, Kathryn G. Roberts, Joseph T. Opferman, Robin Norris, Ryan J. Mattison, Shaun A. Fleming, Seong Lin Khaw, Susan I. Colace, Jessica Leonard, Theodore W. Laetsch, Ashish Bajel, Jeffrey E. Rubnitz, Elias Jabbour, Norman J. Lacayo, Vinod A. Pullarkat
Combining venetoclax, a selective BCL2 inhibitor, with low-dose navitoclax, a BCL-XL/BCL2 inhibitor, may allow targeting of both BCL2 and BCL-XL without dose-limiting thrombocytopenia associated with navitoclax monotherapy. The safety and preliminary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45bfde002b935bce0e2049afbee2a4b
https://doi.org/10.1158/2159-8290.c.6549358.v1
https://doi.org/10.1158/2159-8290.c.6549358.v1
Autor:
Wendy Stock, Thomas B. Alexander, Charles G. Mullighan, Amanda Jacobson, Su Young Kim, Lindsey Rosenwinkel, Deeksha Vishwamitra, Jeremy A. Ross, Yan Sun, John C. Pesko, Bo Tong, Michelle Schmidt, Mohamed Badawi, Chunxu Qu, Yaqi Zhao, Kathryn G. Roberts, Joseph T. Opferman, Robin Norris, Ryan J. Mattison, Shaun A. Fleming, Seong Lin Khaw, Susan I. Colace, Jessica Leonard, Theodore W. Laetsch, Ashish Bajel, Jeffrey E. Rubnitz, Elias Jabbour, Norman J. Lacayo, Vinod A. Pullarkat
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a7a73d874845837c5236e29615a265
https://doi.org/10.1158/2159-8290.22540348.v1
https://doi.org/10.1158/2159-8290.22540348.v1
Autor:
Arthur Nguyen, Joseph S Bubalo, Jennifer N. Saultz, Brandon Hayes-Lattin, Andy Chen, Rachel J. Cook, Arpita Gandhi, Jessica Leonard, Richard T. Maziarz, Yazan Migdady, Eneida R. Nemecek, Levanto Schachter
Publikováno v:
Blood. 140:12856-12858
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e84ded80ad352d347ffbbca42c01363e
https://doi.org/10.1182/blood-2022-156011
https://doi.org/10.1182/blood-2022-156011
Autor:
Krish Patel, Jakub Svoboda, Bijal D. Shah, Bruce D. Cheson, Georges Azzi, Kashyap Patel, Andrew J Cowan, Lori Muffly, Heidi Simmons, Mark Schliekelman, Jessica Leonard
Publikováno v:
Blood. 140:5192-5194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d6b9ee555369e2071304ffc77aa10e2
https://doi.org/10.1182/blood-2022-167669
https://doi.org/10.1182/blood-2022-167669
Autor:
Alexandra P. Kass, Traci M. Kazmerski, Elana Bern, Sabina Sabharwal, Jessica Leonard, Moira Harrison, Katherine Barnico, Tracy Richmond, Gregory S. Sawicki
Publikováno v:
Journal of Cystic Fibrosis.
Maintaining a healthy weight is a focus of Cystic Fibrosis (CF) care. With the increased use of highly effective CFTR modulators, many people with CF are gaining weight more easily, which may affect eating habits and body image. This study investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ff228e5cea718ca6b1690dabed17e1
https://doi.org/10.1016/j.jcf.2022.11.006
https://doi.org/10.1016/j.jcf.2022.11.006
Autor:
Curtis A. Lachowiez, Nicola Long, Jennifer Saultz, Arpita Gandhi, Laura F. Newell, Brandon Hayes-Lattin, Richard T. Maziarz, Jessica Leonard, Daniel Bottomly, Shannon McWeeney, Jennifer Dunlap, Richard Press, Gabrielle Meyers, Ronan Swords, Rachel J. Cook, Jeffrey W. Tyner, Brian J. Druker, Elie Traer
Publikováno v:
Blood advances.
Risk stratification in acute myeloid leukemia (AML) remains principle for survival prognostication and treatment selection. The 2022 European LeukemiaNet (ELN) recommendations were recently published, with notable updates to risk group assignment. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd5ab4b230718af1d7c207b9e6db2f2
https://pubmed.ncbi.nlm.nih.gov/36441905
https://pubmed.ncbi.nlm.nih.gov/36441905